Electronic database made up of medical records from Primary Care destined for pharmacoepidemiologic studies and belonging to the Spanish Agency of Medicines and Medical Devices (AEMPS).
Name in original language
-
Initiative overview
Spain's BIFAP (Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria) is an electronic database comprising anonymised medical records from primary care settings. Managed by the Spanish Agency of Medicines and Medical Devices (AEMPS), BIFAP serves as a critical resource for pharmacoepidemiological studies, enabling the evaluation of medication safety and effectiveness within the Spanish population.
Key Features:
- Data Source: BIFAP aggregates anonymised clinical data from primary care physicians across Spain, focusing on medication prescriptions, patient demographics, and health outcomes.
- Research Applications: The database supports a wide range of pharmacoepidemiological research, including post-authorisation safety studies, risk-benefit analyses, and the identification of adverse drug reactions.
- Collaboration and Oversight: Developed and funded by AEMPS, BIFAP operates with the support of professional medical societies such as the Spanish Society of Family and Community Medicine (SEMFYC), the Spanish Society of Rural and General Medicine (SEMERGEN), and the Spanish Association of Primary Care Paediatrics (AEPAP).
- Scientific Advisory: A scientific committee oversees the project, ensuring methodological rigor and ethical compliance in research activities.
- International Collaboration: BIFAP collaborates with international pharmacoepidemiological research initiatives, contributing to global efforts in medication safety surveillance.
Name of responsible organisation (in English)
Spanish Agency of Medicines and Medical Devices
